Antiphospholipid Antibodies and Systemic Scleroderma
Authors:
Open Access
- 1 March 2013
- journal article
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 30 (1) , 32-36
Abstract
Objective: Antiphospholipid antibodies (APLs) could be associated with an increased risk of vascular pathologies in systemic scleroderma. The aim of our study was to search for APLs in patients affected by systemic scleroderma and to evaluate their involvement in the clinical manifestations of this disease.\ud Materials and Methods: We conducted a cross-sectional descriptive study, from January 2009 until August 2010, with patients received at the Department of Dermatology (Dakar, Senegal). Blood samples were taken at the hematology laboratory and were analyzed for the presence of APLs.\ud Results: Forty patients were recruited. Various types of either isolated or associated APLs were found in 23 patients, i.e. 57.5% of the study population. The most frequently encountered antibody was IgG anti-β2 GPI (37.5% of the patients), followed by anticardiolipins (17.5%) and lupus anticoagulants (5%). No statistically significant association of positive antiphospholipid-related tests to any of the scleroderma complications could be demonstrated.\ud Conclusion: A high proportion of patients showing association of systemic scleroderma and APLs suggests the presence of a morbid correlation between these 2 pathologies. It would be useful to follow a cohort of patients affected by systemic scleroderma in order to monitor vascular complications following confirmation of the presence of antiphospholipid syndromeKeywords
This publication has 12 references indexed in Scilit:
- Epidemiology of systemic sclerosisCurrent Opinion in Rheumatology, 2012
- Systemic sclerosis sine scleroderma associated with antiphospholipid syndromeRheumatology International, 2010
- Clinical significance of antiphospholipid antibodies in Indian scleroderma patientsRheumatology International, 2009
- Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit?Clinical Rheumatology, 2009
- Scleroderma (systemic sclerosis) among NigeriansClinical Rheumatology, 2009
- Invitation to a debate on the serological criteria that define the antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2008
- [Relation between lupus-antiphospholipids antibodies and heart disorders].2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- HUGHES (ANTIPHOSPHOLIPID) SYNDROMERheumatic Disease Clinics of North America, 2001
- Clinical Significance of Anticardiolipin Antibodies in Patients with Systemic SclerosisAutoimmunity, 1995